HomeMarketsEarningsNevro (NVRO) CEO On Chronic Pain Treatments

Nevro (NVRO) CEO On Chronic Pain Treatments

Nevro (NVRO) is a medical device company that delivers solutions for the treatment of chronic pain. CEO Kevin Thornal joins Oliver Renick to give an overview of the company. NVRO is up over 16% this month. Thornal discusses the latest developments in chronic pain treatments. He then goes over NVRO’s earnings. Its adjusted EPS came in at -$0.65 versus an estimated -$0.77 and revenue came in at $103.86M versus an estimated $96.35M. He also outlines the acquisition of Vyrsa Technologies. Tune in to find out more about the stock market today.

Morning Trade Live

08 Dec 2023

SHARE

ON AIR
6:00 pm
The Watch List
5:00 am
Gamma On
REPLAY
5:30 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:00 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
ON AIR
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
education
3:00 am
Inside the Mind of a Trader
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor